Skip to main content

About CRUK Scotland Institute

Find out what we do, how we do it and why we do what we do.

A person walks across a city street at sunset, with tall buildings lining the road on both sides.

Life in Glasgow

Find out about living and working in Glasgow and Scotland.

Our Research

Explore the science at CRUK Scotland Institute. Our research groups, the people who lead them, and how we work.

Operations

The teams and services that keep the Institute running and support our research.

Partners

The networks and organisations we work with to accelerate cancer research.

Careers & Study

Jobs, studentships and opportunities for students at every stage at our world-renowned cancer research institute.

Studentships

PhD opportunities at the Institute

Studentship Vacancies

Open studentships to apply for

Internships

For undergraduate and masters students

Metastasis and Circadian Rhythm

Group Leader:
Dr Zoi Diamantopoulou

Our lab investigates the role of the circadian rhythm in cancer metastasis, with a particular focus on Circulating Tumour Cells (CTCs). Building on our discovery that the metastatic dissemination of breast cancer occurs predominantly during sleep, we aim to determine how the circadian rhythm influences CTC biology, metastatic progression and the response to anticancer therapies.

By integrating in vivo mouse models, microfluidics, robotic technologies, genetic engineering, next-generation sequencing, and spatial transcriptomics with analyses of patient blood samples, we aim to uncover the molecular mechanisms linking circadian rhythms to metastasis across multiple cancer types and identify new therapeutic vulnerabilities.

Ultimately, our research seeks to harness the biology of time to develop innovative anti-metastatic strategies and advance chronotherapy, paving the way for more effective cancer treatments.

A blue pencil icon tilted diagonally, drawing a horizontal line on a plain light grey background.

Lab Reports

click here to read
Blue icon of a document with horizontal lines representing text and a folded bottom right corner, on a light grey background.

Recent Publications

click here to read
A pink icon of three people on a light grey background, with one person in front and two slightly behind on either side, representing a group or community.

Lab Members

click here to read

Recent Publications

2026

Pall GS, Melo C, Ortega-Campos SM, Diamantopoulou Z. Designing the Perfect Strike Against Cancer: Clocking In with the Circadian Rhythm. Annual Review of Cancer Biology. 2026;10:157-178

2025

Saini M, Castro-Giner F, Hotz A, Sznurkowska MK, Nüesch M, Cuenot FM, Budinjas S, Bilfeld G, Ildız ES, Strittmatter K, Krol I, Diamantopoulou Z, Paasinen-Sohns A, Waldmeier M, Cássio R, Kreutzer S, Kontarakis Z, Gvozdenovic A, Aceto N. StealTHY: An immunogen-free CRISPR platform to expose concealed metastasis regulators in immunocompetent models. Cell. 2025.

2023

Diamantopoulou Z, Gvozdenovic A, Aceto N. A new time dimension in the fight against metastasis. Trends Cell Biol. 2023.

Ginn L, Maltas J, Baker MJ, Chaturvedi A, Wilson L, Guilbert R, Amaral FMR, Priest L, Mole H, Blackhall F, Diamantopoulou Z, Somervaille TCP, Hurlstone A, Malliri A. A TIAM1-TRIM28 complex mediates epigenetic silencing of protocadherins to promote migration of lung cancer cells. Proc Natl Acad Sci U S A. 2023;120(40):e2300489120.

2022

Scheidmann MC, Castro-Giner F, Strittmatter K, Krol I, Paasinen-Sohns A, Scherrer R, Donato C, Gkountela S, Szczerba BM, Diamantopoulou Z, Muenst S, Vlajnic T, Kunz L, Vetter M, Rochlitz C, Taylor V, Giachino C, Schroeder T, Platt RJ, Aceto N. An In Vivo CRISPR Screen Identifies Stepwise Genetic Dependencies of Metastatic Progression. Cancer Res. 2022;82:681-694.

Diamantopoulou Z, Castro-Giner F, Schwab FD, Foerster C, Saini M, Budinjas S, Strittmatter K, Krol I, Seifert B, Heinzelmann-Schwarz V, Kurzeder C, Rochlitz C, Vetter M, Weber WP, Aceto N. The metastatic spread of breast cancer accelerates during sleep. Nature. 2022;607:156-162.

2020

Diamantopoulou Z, Castro-Giner F, Aceto N. Circulating tumor cells: Ready for translation? J Exp Med. 2020;217.

2018

Woroniuk A, Porter A, White G, Newman DT, Diamantopoulou Z, Waring T, Rooney C, Strathdee D, Marston DJ, Hahn KM, Sansom OJ, Zech T, Malliri A. STEF/TIAM2-mediated Rac1 activity at the nuclear envelope regulates the perinuclear actin cap. Nature Communications. 2018;9:2124.

Chatzileontiadou DSM, Tsika AC, Diamantopoulou Z, Delbé J, Badet J, Courty J, Skamnaki VT, Parmenopoulou V, Komiotis D, Hayes JM, Spyroulias GA, Leonidas DD. Evidence for Novel Action at the Cell-Binding Site of Human Angiogenin Revealed by Heteronuclear NMR Spectroscopy, in silico and in vivo Studies. ChemMedChem. 2018;13:259-269.

2017

Diamantopoulou Z, White G, Fadlullah MZH, Dreger M, Pickering K, Maltas J, Ashton G, MacLeod R, Baillie GS, Kouskoff V, Lacaud G, Murray GI, Sansom OJ, Hurlstone AFL, Malliri A. TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial Cells. Cancer Cell. 2017;31:621-634.e626.

2015

Whalley HJ, Porter AP, Diamantopoulou Z, White GRM, Castañeda-Saucedo E, Malliri A. Cdk1 phosphorylates the Rac activator Tiam1 to activate centrosomal Pak and promote mitotic spindle formation. Nature Communications. 2015;6:7437.

Diamantopoulou Z, Gilles ME, Sader M, Cossutta M, Vallée B, Houppe C, Habert D, Brissault B, Leroy E, Maione F, Giraudo E, Destouches D, Penelle J, Courty J, Cascone I. Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy. Oncotarget. 2017;8:90108-90122.

2012

Pappa EV, Zompra AA, Diamantopoulou Z, Spyranti Z, Pairas G, Lamari FN, Katsoris P, Spyroulias GA, Cordopatis P. Structure-activity studies of lGnRH-III through rational amino acid substitution and NMR conformational studies. Biopolymers. 2012;98:525-534.

Diamantopoulou Z, Kitsou P, Menashi S, Courty J, Katsoris P. Loss of receptor protein tyrosine phosphatase β/ζ (RPTPβ/ζ) promotes prostate cancer metastasis. J Biol Chem. 2012;287:40339-40349.

2011

Pappa EV, Zompra AA, Spyranti Z, Diamantopoulou Z, Pairas G, Lamari FN, Katsoris P, Spyroulias GA, Cordopatis P. Enzymatic stability, solution structure, and antiproliferative effect on prostate cancer cells of leuprolide and new gonadotropin-releasing hormone peptide analogs. Biopolymers. 2011;96:260-272.

2010

Diamantopoulou Z, Bermek O, Polykratis A, Hamma-Kourbali Y, Delbé J, Courty J, Katsoris P. A Pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζ. Molecular Cancer. 2010;9:224.

2007

Bermek O, Diamantopoulou Z, Polykratis A, Dos Santos C, Hamma-Kourbali Y, Burlina F, Delbé J, Chassaing G, Fernig DG, Katsoris P, Courty J. A basic peptide derived from the HARP C-terminus inhibits anchorage-independent growth of DU145 prostate cancer cells. Exp Cell Res. 2007;313:4041-4050.

Group Leader

Smiling person with long curly hair and glasses, wearing a light blue shirt, standing in front of a neutral background.

Lab Members

PhD Student

Abstract illustration of a faceless person in a lab coat inside a circle, surrounded by clusters of blue, pink, and purple dots and lines resembling molecular structures on a light background.

Carolina Lopes Melo

I’m a PhD student exploring how the circadian rhythm regulates the generation of circulating tumour cells. Originally from Portugal, I moved to Scotland to learn about this emerging field in cancer research and, hopefully, contribute to new chronotherapy strategies for cancer patients. It’s exciting to work surrounded by people with such diverse expertise and ideas. Outside the lab, I try to stay creative through knitting, pottery, and design, though more often you’ll find me simply hanging out with friends. 

Postdoctoral Fellow

Abstract illustration of a faceless person in a lab coat inside a circle, surrounded by clusters of blue, pink, and purple dots and lines resembling molecular structures on a light background.

Chloe Petitpas

I have started my first postdoctoral position at the CRUK SI, where I am investigating how the circadian rhythm drives metastatic growth by shaping the plasticity of the tumour microenvironment, with a focus on immune cells. I did my PhD in Marseille, France, during which I developed my interest in immunology by studying how chronic wounds and inflammation promote tumorigenesis in epithelial junctions. Out of the lab, I enjoy spending time in nature with my family, practising diverse sports, and watching anime. 

Principal Scientific Officer

A woman with long brown hair smiling outdoors in front of trees and a pond.

Emily Kay

I joined the institute in 2015 to do my PhD investigating the role of proline metabolism in the tumour microenvironment. After my PhD, I continued this research, focussing on the immune microenvironment, first as a Post doc and then as an Associate Scientist. In 2026, I moved to Zoi’s group where I work on how circadian rhythms affect cancer metastasis and interactions between cancer cells and the tumour microenvironment, as well as supporting the day to day running of the lab. Outside of the lab I enjoy singing in choirs, swimming and reading books. 

 

Msci Student

A young woman with her hair tied back wears a light pink button-up jumper.

Scarlet Davies

I am a 4th year Immunology MSci student from the University of Glasgow, and I am undergoing my work placement year carrying out research within circadian rhythm and cancer metastasis. Currently investigating the expression of circadian associated genes in pancreatic and colorectal cancer models, exploring potential disruptions to circadian clock in tumour tissue. Out with the lab I enjoy running, all types of music and travelling to as many countries as I can! 

Secret Link